A5055130839- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- HIV Research and Treatment
- HIV-related health complications and treatments
- Child Nutrition and Water Access
- HIV/AIDS Impact and Responses
- Viral Infections and Outbreaks Research
- Healthcare Systems and Practices
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- Ethics in Clinical Research
- Global Health and Surgery
- HIV, Drug Use, Sexual Risk
- COVID-19 epidemiological studies
- Aging, Elder Care, and Social Issues
- Childhood Cancer Survivors' Quality of Life
- Parkinson's Disease and Spinal Disorders
- Child Nutrition and Feeding Issues
- Cervical and Thoracic Myelopathy
- COVID-19 Clinical Research Studies
- Vaccine Coverage and Hesitancy
- Global Maternal and Child Health
- Delphi Technique in Research
- Food Security and Health in Diverse Populations
- Breastfeeding Practices and Influences
Central Hospital of Yaoundé
2020-2023
Agropolis International
2020-2023
Inserm
2016-2023
Université de Montpellier
2016-2023
Agence Nationale de Recherches sur le Sida et les Hépatites Virales
2020-2023
Institut de Recherche pour le Développement
2016-2023
National Radiation Protection Agency of Cameroon
2021-2023
Université de Dschang
2023
Ministry of Public Health
2022
Military Hospital
2022
Abstract Background Achieving the UNAIDS 95% sustained viral suppression (VS) rate requires considerable global efforts, particularly among adolescents living with HIV (ALHIV) who are often associated high rates of virological failure (VF). In this study, we prospectively assessed VS, and factors VF in a cohort followed up according to WHO guidelines Cameroon. Methods A cross-sectional study was carried out 2021 (aged 10–19 years) receiving ART national program Socio-demographic clinical...
We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27-February 6 and April 24-May 19, 2021. Overall age-standardized IgG seroprevalence increased from 18.6% the first survey to 51.3% second (p<0.001). This finding illustrates high community transmission wave of COVID-19.
We aimed to estimate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence among general population in Conakry, Guinea and Yaounde, Cameroon after disease 2019 Omicron wave.We conducted population-based, age-stratified surveys Conakry Yaounde (May June 2022). collected demographic epidemiologic information dried blood spot samples that were tested for SARS-CoV-2 immunoglobulin G (IgG) antibodies using recombinant nucleocapsid spike proteins with Luminex...
Evidence comparing the economic and patient values of World Health Organization's preferred (dolutegravir 50 mg [DTG]-based) alternative (low-dose [400 mg] efavirenz [EFV400]-based) first-line antiretroviral regimens is limited. We compared patient-reported outcomes (PROs), costs, cost-utility DTG- versus EFV400-based in treatment-naive HIV-1 adults randomised NAMSAL ANRS 12313 trial Yaoundé, Cameroon. used clinical data, PROs, health resource use data collected trial's first 96 weeks...
To assess the acceptability of ready-to-use food (RUF)-based outpatient protocols in HIV-infected children and adolescents with severe acute malnutrition (SAM) moderate (MAM).Plumpy Nut Plumpy Sup were supplied every 2 weeks prescribed by weight to SAM MAM children, respectively. Forty-three 24 19 SAM, enrolled. Organoleptic appreciation, feeding modalities, perceptions surrounding RUF recorded at week 2. Sachets counted measure adherence throughout study.Median age was 12.2 years...
Abstract Background Ready-to-use food (RUF) is increasingly used for nutritional therapy in HIV-infected individuals. However, practical guidance advising nutrition care to adolescents lacking, so that little known about the acceptability of such this vulnerable population. This study assesses overall and perception a RUF-based risk factors associated with sub-optimal RUF intake undernourished Senegal. Methods Participants 5 18 years age acute malnutrition were enrolled 12 HIV clinics...
Background: We provide new and comprehensive evidence on the evolution of a wide range patient-reported outcomes (PROs) in NAMSAL ANRS 12313 trial Cameroon (2016–2021)—the first randomized comparison dolutegravir 50 mg (DTG) low-dose efavirenz (ie, 400 mg; EFV400) treatment-naive adults living with HIV-1 sub-Saharan Africa. Methods: described PROs between baseline week 192. Then, we used random-effects models to measure effect time since initiation antiretroviral therapy differential DTG...
Abstract Objectives Providing research information in a manner accessible to minors participating biomedical is major challenge. Guidance dramatically lacking regarding best practices for seeking informed consent among undisclosed enrolled HIV‐related research. We implemented an improved process (IICP) and identified factors associated with understanding of the presented HIV‐infected prior their enrolment study. Methods study participants attending 12 paediatric HIV clinics Senegal. Children...
Introduction: the Treat-All remains globally endorsed approach to attain 95-95-95 targets and end AIDS pandemic by 2030, but requires some country-level contextualization. In Cameroon, specific research agenda inform strategies for improving HIV policy was yet be defined.
Relations between ethnicity and child malnutrition in rural Benin. In a therapeutic feeding center northern Benin, we found disparities the three main ethnic groups proportions of children hospitalized; undernutrition seemed more frequent severe Gando than Bariba Fulani groups. This survey sought to identify risk factors for malnutrition. We used standardized questionnaire interview women from these groups, all with aged 5 years or younger. The study included 165 mothers 62 whom had weaned...
Abstract Background A prospective study was extended to the new antiretroviral and monitoring strategies in HIV-infected adults low-income countries (NAMSAL-ANRS)-12313 trial, a 96-week open-label, multicenter, randomized phase 3 trial comparing dolutegravir (DTG) 50 mg with efavirenz 400 (EFV400), both administered tenofovir disoproxil fumarate lamivudine (TDF/3TC) as first-line treatment for therapy (ART)–naive people living human immunodeficiency virus type 1 (HIV). Noninferiority of DTG...
In view of the worldwide epidemic processes that require and result in simultaneous research several countries an increasingly more structured scientific community, especially Global South, it is essential to establish partnerships between researchers, policy-makers, local supervisors, communities both North South. The objectives this essay are to: 1) present context issues linked framework a North-South partnership; 2) describe development appropriate responses improve consideration ethical...
Research is a vital component for the development of any country. In Cameroon, HIV Operational research rapidly growing, however, it faces some intractable problems which can only be solved through an urgent, strategic, efficient, and collaborative approach involving key stakeholders. The Kribi meeting (09 10th December 2020) brought together under auspices Ministry Public Health leading organisations connected researchers actors from different sectors. These disseminated discussed recent...